Home › Funds › ARMISTICE CAPITAL, LLC › IRWD

ARMISTICE CAPITAL, LLC position in IRWD

IRONWOOD PHARMACEUTICALS INC · Health Care

ARMISTICE CAPITAL, LLC reported holding 15,000,000 shares of IRWD (IRONWOOD PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$59.5M, representing 0.81% of its reported portfolio and ranking #10 among its reported holdings. ARMISTICE CAPITAL, LLC has disclosed IRWD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)15.00M sh
Reported value held$59.55M
Portfolio Weight0.81%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ARMISTICE CAPITAL, LLC's IRWD position evolved

ARMISTICE CAPITAL, LLC first disclosed a stake in IRWD in Q3 2023 at 3,456,000 shares (US$33.3M). The position peaked in Q4 2023 at 5,700,000 shares, worth US$65.2M. Across 13 filings, ARMISTICE CAPITAL, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 15,000,000 shares valued at US$59.5M — an increase of 1,068,000 shares quarter over quarter.. Notable position changes include a 65% increase in Q4 2023 (shares fell 24% over the following quarter), a 44% increase in Q2 2024 (shares fell 37% over the following quarter), a 45% increase in Q1 2025 (shares fell 53% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.46M $33.28M New
Q4 2023 5.70M $65.21M Add
Q1 2024 5.40M $47.03M Reduce
Q2 2024 7.80M $50.86M Add
Q3 2024 8.20M $33.78M Add
Q4 2024 9.47M $41.94M Add
Q1 2025 13.70M $20.14M Add
Q2 2025 16.15M $11.58M Add
Q3 2025 16.15M $21.16M Hold
Q4 2025 16.02M $54.00M Reduce
Q1 2026 15.03M $52.75M Reduce
Q2 2026 13.93M $58.65M Reduce
Q3 2026 15.00M $59.55M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRWD and 13F data

IRWD (IRONWOOD PHARMACEUTICALS INC) is a Health Care company. 20 other funds we track also report a position in IRWD — the largest reported positions include Sarissa Capital Management LP (US$38.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRWD

All IRWD fund holders →

FAQ

How long has ARMISTICE CAPITAL, LLC held IRWD?

ARMISTICE CAPITAL, LLC has disclosed IRWD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ARMISTICE CAPITAL, LLC's current position in IRWD?

As of Q3 2026, ARMISTICE CAPITAL, LLC holds 15.00M shares of IRWD (IRONWOOD PHARMACEUTICALS INC), valued at $59.55M, representing 0.81% of its reported portfolio and ranking #10.

Has ARMISTICE CAPITAL, LLC been buying or selling IRWD?

In the latest 13F filing (Q3 2026), ARMISTICE CAPITAL, LLC increased its position in IRWD. The position peaked in Q4 2023 at 5.70M shares.

Which other funds hold IRWD?

Other major institutional holders of IRWD include Sarissa Capital Management LP, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.